Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Richard C. Prokesch"'
Autor:
Clifford P Martin, Thomas K Sleweon, Quyen Luu, Richard C Prokesch, Robin H Dretler, Barry Statner, Kent J Stock, Claudia P Schroeder, Lucinda J Van Anglen
Publikováno v:
Open Forum Infectious Diseases. 9
Background Outpatient parenteral antimicrobial therapy (OPAT) has been shown to be safe and effective for self-administration but can lead to non-adherence without supervision. A physician office infusion center (POIC) with pharmacy services provides
Autor:
Richard C. Prokesch
Publikováno v:
Fundamentals of HIV Medicine 2021 ISBN: 0197576591
This chapter provides a summary overview of the COVID-19 pandemic and how it impacts people with HIV and special considerations for healthcare providers. It summarizes the findings of investigations aimed to determine if people with HIV are more susc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74f7aa02069ae2db1f46ec8decf9fe51
https://doi.org/10.1093/med/9780197576595.003.0043
https://doi.org/10.1093/med/9780197576595.003.0043
Autor:
Brian S Metzger, Richard C Prokesch, Jorge R Bernett, Richard M Mandel, Ramesh V Nathan, Kent Stock, Thomas C Hardin, Claudia P Schroeder, Lucinda J Van Anglen
Publikováno v:
Open Forum Infectious Diseases
Background Long-acting lipoglycopeptides (LGPs) are approved for the treatment of acute bacterial skin and skin-structure infections. Broad Gram-positive coverage and weekly dosing regimens are useful for other diagnoses, but real-world data supporti
Autor:
Richard C. Prokesch, Brian S Metzger, Richard M. Mandel, Jorge R. Bernett, Carson T Lo, Claudia P. Schroeder, John S. Adams, Lucinda J. Van Anglen, Thomas C. Hardin
Publikováno v:
Open Forum Infectious Diseases
Background A significant complication of prosthetic joint replacement is the development of a PJI. Therapy includes prolonged IV antibiotics (IVAB), usually delivered in the outpatient setting. Follow-up (FU) in this population can be difficult, part
Autor:
Quyen Luu, Lucinda J. Van Anglen, Alfred E. Bacon, Richard C. Prokesch, Claudia P. Schroeder, Carson T Lo, Ramesh V Nathan, Richard L Hengel, Kimberly A Couch, H. Barry Baker
Publikováno v:
Open Forum Infectious Diseases
Background The Hospital Readmissions Reduction Program was established under the Affordable Care Act in 2012 to reduce payments to hospitals (hosp) with excess readmissions. Standardized readmission measures include all-cause unplanned readmissions w
Publikováno v:
Open Forum Infectious Diseases
Background Ibalizumab-uiyk (IBA) was recently approved for the treatment of multi-drug-resistant HIV-1 infection in patients (pts) failing other antiretroviral regimens. Clinical trial data demonstrated a decrease in HIV-1 viral load in 83% and 43% o
Autor:
Andrew H. Krinsky, John S. Adams, Claudia P. Schroeder, Quyen Luu, Richard C. Prokesch, Lucinda J. Van Anglen, Robin H. Dretler
Publikováno v:
International journal of antimicrobial agents. 50(1)
Telavancin is a lipoglycopeptide antibiotic with bactericidal activity against Gram-positive pathogens including Staphylococcus aureus , the most frequent cause of osteomyelitis. Treatment is often challenging due to needs for surgical intervention a
Autor:
Quyen Luu, Lucinda J. Van Anglen, Ramesh V Nathan, Thomas K Sleweon, Richard C. Prokesch, Claudia P. Schroeder, Fernando S. Alvarado
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Claudia P. Schroeder, H. Barry Baker, Lucinda J. Van Anglen, Richard C. Prokesch, Quyen Luu, Robin H. Dretler, Andrew H. Krinsky
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Robin H. Dretler, Andrew H. Krinsky, Quyen Luu, Claudia P. Schroeder, Lucinda J. Van Anglen, John S. Adams, Brian D. Metzger, Richard C. Prokesch
Publikováno v:
Open Forum Infectious Diseases. 2